Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Women Complain About Contraceptive Implant

By Drug Discovery Trends Editor | January 6, 2011

LONDON (AP) – Hundreds of women in Britain have complained to the medical regulator after becoming pregnant despite using a contraceptive implant that is supposed to work for years.

But the implant’s maker, Merck & Co., says the failure rate isn’t exceptional, and that women should continue to use it.

Implanon contains synthetic progesterone and is inserted underneath the skin in the upper arm, where it is supposed to stop pregnancies for up to three years. More than 1 million implants have been sold since it was licensed in Britain in 1999.

On Wednesday, the Medicines and Healthcare Products Regulatory Agency said it had received more than 1,500 complaints of side effects – including pain and scarring – linked to Implanon since 1999. 584 women said they had suffered unplanned pregnancies.

Ronald Rogers, a spokesman for the New Jersey-based company, said the number of women in Britain who became pregnant were within the range the company would expect for that time period.

“We’re very confident in the efficacy and safety of Implanon,” Rogers said, adding it is more than 99 percent effective. He would not comment on whether other countries have reported higher than expected pregnancy rates in women who use Implanon.

Rogers said 600 pregnancies among Implanon’s 1 million UK users translates into a rate of less than one percent. No form of contraception is 100 percent effective, he added.

Britain’s healthcare regulator said in a statement that Implanon is a safe, effective and reliable contraceptive “when used correctly.”

The agency recommended that any women worried about their contraceptive implants should use a condom as well for extra protection or talk to their doctor.

Date: January 6, 2010
Source: Associated Press


Filed Under: Drug Discovery

 

Related Articles Read More >

Sai Life Sciences exec: GLP-1 boom has ‘exploded the peptide field’ as firm opens new center
Novartis in the Pharma 50
Swissmedic approves first malaria treatment for infants
Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE